Abstract
The combination of clindamycin and primaquine was investigated as primary treatment for mild or moderately severePneumocystis carinii pneumonia (alveolar-arterial oxygen gradient <40 torr) in 36 AIDS patients. All patients were treated with primaquine 30 mg (base) orally for 21 days. The first 22 patients were treated with clindamycin 900 mg i.v. q8h for the first 10 days, followed by clindamycin 450 mg q6h orally for 11 days. Twenty of these 22 patients (91 %) showed a marked clinical response by day 7. Four patients were later withdrawn from the study due to toxicity. An additional 14 patients were treated with an entirely oral regimen of clindamycin and primaquine. Thirteen of the 14 patients (93 %) showed a marked therapeutic response and 12 (86 %) successfully completed treatment. The combination of clindamycin and primaquine appears to be an effective and well-tolerated treatment for mild to moderately severePneumocystis carinii pneumonia in AIDS patients.
Similar content being viewed by others
References
Queener SF, Bartlett MS, Richardson JD, Durkin MM, Jay MA, Smith JW Activity of clindamycin with primaquine againstPneumocystis carinii in vitro and in vivo. Antimicrobial Agents and Chemotherapy 1988, 32: 807–813.
Hand WL, Boozer RM, King-Thompson NL Antibiotic uptake by alveolar macrophages of smokers. Antimicrobial Agents and Chemotherapy 1985, 27: 42–45.
Clark AM, Baker JK, McChesney JD Excretion, distribution, and metabolism of primaquine in rats. Journal of Pharmaceutical Sciences 1984, 73: 502–506.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Black, J.R., Feinberg, J., Murphy, R.L. et al. Clindamycin and primaquine as primary treatment for mild and moderately severePneumocystis carinii pneumonia in patients with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 10, 204–207 (1991). https://doi.org/10.1007/BF01964465
Issue Date:
DOI: https://doi.org/10.1007/BF01964465